BZW2 Inhibitors
BZW2 inhibitors constitute a specialized category of chemical compounds designed to selectively target and impede the function of the BZW2 protein, a factor involved in cellular processes such as gene expression and protein synthesis. The BZW2 protein, encoded by a specific gene, plays a role in the translation initiation complex, which is crucial for the commencement of protein synthesis in cells. Inhibitors of BZW2 are structured to disrupt this complex's formation or stability, thereby interfering with the initiation step of protein synthesis. These inhibitors are often small molecules that can bind to the BZW2 protein or its associated factors, preventing the necessary conformational changes or interactions needed for the translation initiation complex to function properly. The inhibition of BZW2 can result in a downstream decrease in the production of various proteins, affecting cellular growth and proliferation. This makes the BZW2 inhibitors particularly interesting in the study of cellular biology and the regulation of gene expression, as they provide a tool to dissect the intricacies of protein synthesis at the molecular level.
The action of BZW2 inhibitors can be highly specific, targeting unique domains within the BZW2 protein that are essential for its activity. By binding to these domains, the inhibitors can effectively reduce the activity of BZW2 without necessarily affecting other proteins within the same pathway, leading to a decrease in protein synthesis only in cells where BZW2 is active. This specificity arises from the molecular structure of the inhibitors, which is usually designed based on the three-dimensional structure of BZW2 or through high-throughput screening methods that identify potential inhibitory compounds. The specificity of BZW2 inhibitors offers a powerful approach to study the role of BZW2 in various cellular processes. By selectively disrupting BZW2 function, researchers can observe the resultant effects on cell behavior, gene expression patterns, and overall protein production. This information is vital for understanding the fundamental mechanisms that govern cell function and for identifying how alterations in protein synthesis can affect cellular homeostasis.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
This compound is a MEK inhibitor, which consequently can suppress the ERK/MAPK signaling pathway. Since BZW2 is a transcriptional regulator that might be influenced by the downstream effects of MAPK signaling, PD98059 could lead to reduced BZW2 activity by hindering the pathway’s input into the transcriptional machinery. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K signaling is vital for several cellular processes, including growth and survival. BZW2 has been associated with cellular growth control, and inhibiting PI3K can reduce the signaling required for BZW2 to execute its functions. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, Rapamycin can block the mTOR pathway, which is crucial for protein synthesis and cell growth. By inhibiting mTOR, Rapamycin might decrease the overall cellular context in which BZW2 functions, indirectly reducing its activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This compound inhibits p38 MAPK, a kinase involved in stress responses. BZW2, being a basic leucine zipper protein, may interact with stress response elements; thus, SB203580 could lead to a reduction in BZW2 activity by minimizing stress-mediated signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor, which prevents the activation of MAPK/ERK. ERK is implicated in cell cycle progression and growth, which could indirectly affect BZW2’s role in gene expression by limiting its activation through these pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, SP600125 can impact cellular stress and inflammatory responses. JNK pathway can modulate transcription factors and their activity, potentially influencing the functional capacity of BZW2 within these response pathways. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib targets the EGFR tyrosine kinase which is upstream of several signaling pathways, including MAPK, PI3K, and STAT. By inhibiting EGFR, Gefitinib could consequently reduce the signaling that contributes to BZW2 activity in growth and survival pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor. It can suppress the AKT signaling which is instrumental in cell survival and growth, pathways that may be necessary for BZW2's full activity, thus indirectly inhibiting it. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib is an EGFR inhibitor which can blunt the EGFR-MAPK signaling. By doing so, it may alter the transcriptional regulation in which BZW2 is involved, particularly in the context of cell growth and response to external signals. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib targets multiple tyrosine kinases, including those in the RAS/RAF/MEK/ERK pathway. By broadly inhibiting these kinases, it could indirectly inhibit BZW2 by reducing the signaling required for its activation. | ||||||